Thursday Plenary session

Thursday May 3rd

Meeting room Telemark








0830-0840:


0840-0855: 


0855-0910:


0910-0915: 


Sponsored session Novartis/Sandoz
Rejection in organ transplanted patients: what role does adherence play?
Monitoring of immunosuppressive drugs, gold standards and novel approaches

Chair: Professor Anders Åsberg, Oslo University Hospital, Rikshospitalet, Norway

Current challenges in therapeutic drug monitoring in Scandinavia
Anders Åsberg

A practical solution for TDM using home micro-sampling

James Rudge, Neoteryx LLC, USA

Forming a patient-doctor alliance through home TDM

Jon Jin Kim, Nottingham Children’s Hospital, UK

Discussion & Questions from the audience
Anders Åsberg & Speaker Panel

09:15-10:30Poster + Exhibition with coffee break
Plenary Hall
10:30-11:00Diagnosis of death in DCD - the UK experience
Paul Murphy, Leeds UK
11:00-11:15cDCD in the Nordic countries: Current status
Markus Gäbel, Gothenburg Sweden and
Dag Wendelboe Sørensen, Oslo Norway
11:15-11:45cDCD: Ethical considerations (panel discussion)
Corinne Antoine, Paris France,
Morten Horn, Oslo Norway and Paul Murphy, Leeds, UK and Geir Bjørsvik, Norway
11:45-12:00Coffee break + Exhibition with coffee break
12:00-13:00Sponsored session: Chiesi (lunch):
Different patients, different needs; can we do more?

Chairs: Lars Wennberg - Karolinska University, Hospital, Sweden.
Patients with “recognised” sensitivity to tacrolimus pharmacokinetics: Risk factors and implications for treatment.
Lucrezia Furian – Padua University Hospital, Italy.

Patients with “hidden” sensitivity to tacrolimus pharmacokinetics:
Identification and management.

Klemens Budde – Charité University Hospital, Berlin, Germany

13:00-18:00Parallel Session A and B
19:00-22:00Conference Dinner at Sjømagasinet, Tjuvholmen